Cleared Traditional

K223590 - Access Folate Assay

K223590 is an FDA 510(k) clearance for Access Folate Assay, manufactured by Beckman Coulter, Inc.. The device is a Class 2 Chemistry device with product code CGN cleared through the Traditional 510(k) pathway after a 265-day FDA review.

K223590 · Beckman Coulter, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2023
Decision
265d
Days
Class 2
Risk

K223590 is an FDA 510(k) clearance for the Access Folate Assay. Classified as Acid, Folic, Radioimmunoassay (product code CGN), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Chaska, US). The FDA issued a Cleared decision on August 23, 2023 after a review of 265 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1295 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Beckman Coulter, Inc. devices

FDA 510(k) Submission Details - K223590

510(k) Number K223590 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 01, 2022
Decision Date August 23, 2023
Days to Decision 265 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
177d slower than avg
Panel avg: 88d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGN Device Classification - Class 2, Special Controls

Product Code CGN Acid, Folic, Radioimmunoassay
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1295
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGN Acid, Folic, Radioimmunoassay

All 57
Devices cleared under the same product code (CGN) and FDA review panel - the closest regulatory comparables to K223590.
Elecsys Folate III
K233060 · Roche Diagnostics · Jun 2024
LIAISON® Folate
K192586 · DiaSorin, Inc. · May 2020
Atellica IM Folate Assay
K172201 · Siemens Healthcare Diagnostics, Inc. · Apr 2018
Diazyme Folate Assay , Diazyme Folate Calibrator Set, Diazyme Folate Control Set
K161646 · Diazyme Laboratories · Nov 2016
ELECSYS FOLATE III
K141426 · Roche Diagnostics · Oct 2014
ROCHE ELECSYS FOLATE RBC
K103716 · Roche Diagnostics · May 2011